Who funds CRISPR and gene editing research?

We count 112 funded CRISPR and gene editing projects, active between 2019 and 2033, from 8 funders. The most came from EU · ERC (40 projects), EU · MSCA (20 projects) and Wellcome (11 projects). The median award is $1.7M, across the 106 of 112 projects that list an amount.

Funded projects

112

Funders

8

Median award

$1.7M

Open calls now

1

Top funders of CRISPR and gene editing research

Projects whose title or summary mentions CRISPR and gene editing. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.

Open CRISPR and gene editing funding calls

1 open call mentions CRISPR and gene editing today.

• Collaborate with the functional genomics screening laboratory
  Medical Research Council (MRC)Not specifiedDeadline: Not listed
  Real odds: About 1 in 5 funded (19% · Medical Research Council (MRC), all funding decisions, 2024-25)

Real odds

• About 1 in 5 funded · 19% · Medical Research Council (MRC), all funding decisions, 2024-25 · UKRI investment and outputs data, table 2.1

Published success rates for the programs behind the open calls above: the share of applications the funder funded, program-wide, not for this topic.

Forecast: announced, not open yet

1 forecast call on CRISPR and gene editing. Funders publish forecasts before a call opens; you can't apply to these yet, and dates can change.

• ForecastTesting Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed)
  National Institutes of Health$580,000 – $900,000Expected to open November 25, 2027

Funded CRISPR and gene editing projects

A sample, latest start first, at most three per program.

• Targeting UTR regulation as a gene-level therapeutic strategy for rare disease
  Wellcome · £2,463,362 · ends 2033
• Precision phenotyping of hypertrophic cardiomyopathy for risk stratification and targeted therapeutics.
  Wellcome · £1,946,794 · ends 2032
• Indian Institute of Science Education and Research Thiruvananthapuram — Agricultural Development
  Gates Foundation · $881,563 · ends 2031
• The University of Edinburgh — Agricultural Development
  Gates Foundation · $2,360,668 · ends 2030
• Perennial forest trees, such as poplar, are characterized by long generation times and extended reproductive development that severely…
  USDA · $650,000 · ends 2030
• From mechanism to clinical translation: Understanding the off- and on-target toxicities of nucleic-acid-dependent therapeutics
  UKRI · MRC · £3,437,107 · ends 2030
• Traceless delivery of ‘genome editors’ for treatment of severe genetic diseases
  Wellcome · £741,702 · ends 2030
• Directed enzyme evolution coupled with targeted gene editing (de-ge) offers a valuable new source of genetic variation to improve quality…
  USDA · $617,000 · ends 2030
• Gene editing is being developed globally as a tool to introduce natural genetic variations in agricultural organisms
  USDA · $649,094 · ends 2029
• EDGE-FGT: Enabling CRISPR-Based Functional Genomics of Non-Model, Difficult-To-Manipulate Fungi
  NSF · BIO · $946,383 · ends 2029

How we count

Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “crispr or gene editing or genome editing”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.